In acute spinal cord infarction, how long should mean arterial pressure (MAP) be maintained at ≥85‑90 mm Hg?

Blood Pressure Management Duration in Acute Spinal Cord Infarction

Maintain mean arterial pressure (MAP) ≥85–90 mm Hg for 5–7 days after acute spinal cord infarction, with the most critical period being the first 2–3 days when the correlation between MAP and neurological recovery is strongest. 1, 2, 3

Evidence-Based Duration and Targets

Primary Recommendation (5–7 Days)

• The American Association of Neurological Surgeons/Congress of Neurological Surgeons recommends maintaining MAP > 85 mm Hg continuously for 5–7 days post-injury to optimize spinal cord perfusion and neurological outcomes, though this is based on limited prospective evidence without control groups. 1, 2

• Both prospective studies examining MAP augmentation used a 7-day treatment duration with MAP goals of 85–90 mm Hg, and both demonstrated stable-to-improved neurological outcomes. 3

• The strongest correlation between MAP level and neurological improvement occurs in the first 2–3 days after injury, suggesting this is the most critical window for aggressive blood pressure management. 1, 2

Alternative Conservative Approach

• French guidelines suggest a more conservative MAP > 70 mm Hg may be sufficient, noting insufficient evidence to recommend targets above 70 mm Hg, though this represents a minority position. 1, 2

Critical Implementation Requirements

Monitoring Intensity

• Continuous arterial catheter monitoring is mandatory because MAP falls below target approximately 25% of the time without invasive monitoring, making achievement of narrow target ranges nearly impossible with intermittent cuff measurements. 1, 4

• Minute-to-minute MAP variability averages ~3 mm Hg, meaning the recommended 5 mm Hg target range (85–90 mm Hg) presents significant practical challenges even with optimal monitoring. 4

• Only 24% of MAP recordings fall within the 85–90 mm Hg target range in real-world practice, highlighting the difficulty of maintaining this narrow window. 4

Hypotension Avoidance

• Systolic blood pressure must remain > 110 mm Hg and avoid any episodes of systolic BP < 90 mm Hg through days 5–7, as hypotension at admission is an independent mortality predictor. 1

• The proportion of MAP measurements ≥85 mm Hg is an independent predictor of neurological improvement (p = 0.028), with patients showing neurologic recovery having 81% vs. 72% of readings above target. 5

Treatment Algorithm

Initial Resuscitation (First 24 Hours)

1. Administer intravenous fluids first before initiating vasopressors in patients without contraindications (heart failure, pulmonary edema). 1

2. Insert arterial catheter for continuous MAP monitoring immediately upon diagnosis. 1, 4

3. Treat any MAP drop below 85 mm Hg immediately to prevent secondary ischemic injury. 1

Vasopressor Selection

• Norepinephrine is preferred for cervical and upper thoracic injuries, while phenylephrine or norepinephrine should be considered for mid-to-lower thoracic injuries. 3

• Avoid dopamine as it is associated with more complications than other vasopressors. 3

Days 2–7: Maintenance Phase

• Continue MAP target of 85–90 mm Hg with continuous arterial monitoring through day 7, recognizing that the correlation with neurologic improvement weakens after day 3 but remains clinically relevant. 1, 2, 3

• Patients requiring vasopressors (78% in one series) need particularly close monitoring, as the association between elevated MAP and neurologic improvement is moderated by vasopressor dose. 5

High-Risk Populations Requiring Enhanced Vigilance

• Polytrauma patients are at independent risk for failing to meet MAP targets (p < 0.05) and require more aggressive monitoring and intervention. 6

• Patients with head injury or requiring inotropes also show significantly higher rates of low MAP recordings. 6

Common Pitfalls and How to Avoid Them

Pitfall 1: Inadequate Monitoring Frequency

• Without a structured checklist and staff education, tertiary centers average only 1.3 MAP readings per hour, far below the continuous monitoring needed to detect and correct hypotensive episodes. 6

• Implementation of a hemodynamic safety checklist increases MAP readings to 2.7 per hour and reduces the proportion of patients with >50% of readings <80 mm Hg from 36.5% to 16%. 6

Pitfall 2: Premature Discontinuation

• Do not discontinue MAP augmentation before 5 days unless there are compelling contraindications, as the evidence base specifically supports 5–7 day duration. 1, 2, 3

Pitfall 3: Accepting "Close Enough" Targets

• MAP values of 80–84 mm Hg are insufficient—the evidence specifically demonstrates benefit at ≥85 mm Hg, and outcomes correlate with the proportion of time spent above this threshold. 5

Evidence Quality and Limitations

• No randomized controlled trials exist comparing neurological outcomes at different MAP targets, so current recommendations are based on prospective cohort studies and retrospective analyses. 2, 3, 7

• The 2013 AANS/CNS guidelines acknowledge this recommendation is based on weak evidence for neurologic benefit, though it remains the highest level of evidence available. 7

• Retrospective studies show contradictory results regarding the correlation between BP management and outcomes, while the two prospective studies both demonstrated benefit. 3